RBM6 and prostate carcinoma: Among the above causal associations, substantial colocalization evidence (PPH4 > 0.8) were found linking PSCA to bladder cancer, PM20D1 to prostate cancer, L3MBTL3 to prostate cancer, and RBM6 to skin cancer (Figure 8 and Figure 9).